Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients

Letter/Communication

Open access

Christopher Strouse, Sarah L. Mott, Brian J. Smith, Margarida Magalhaes-Silverman, Umar Farooq, Fenghuang Zhan, Yogesh Jethava and Guido Tricot

Bone marrow transplantation (Basingstoke)

10/10/2023

DOI: 10.1038/s41409-023-02119-9

PMCID: PMC10781621

PMID: 37816907

Files and links (1)

url

https://doi.org/10.1038/s41409-023-02119-9View

Published (Version of record) Open Access

Title: Subtitle: Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients
Creators: Christopher Strouse - University of Iowa
Sarah L. Mott - University of Iowa
Brian J. Smith - University of Iowa, Biostatistics
Margarida Magalhaes-Silverman - University of Iowa
Umar Farooq - University of Iowa
Fenghuang Zhan - Winthrop Rockefeller Foundation
Yogesh Jethava - Indiana Cancer Consortium
Guido Tricot - Winthrop Rockefeller Foundation
Resource Type: Letter/Communication
Publication Details: Bone marrow transplantation (Basingstoke)
DOI: 10.1038/s41409-023-02119-9
PMID: 37816907
PMCID: PMC10781621
NLM abbreviation: Bone Marrow Transplant
ISSN: 0268-3369
eISSN: 1476-5365
Language: English
Date published: 10/10/2023
Academic Unit: Preventive and Community Dentistry; Hematology, Oncology, and Blood & Marrow Transplantation; Biostatistics; Holden Comprehensive Cancer Center; Internal Medicine
Record Identifier: 9984474569202771

9 Record Views